BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14737646)

  • 1. Synthesis and properties of bioactive 2- and 3-amino-8-methyl-8H-quino[4,3,2-kl]acridine and 8,13-dimethyl-8H-quino[4,3,2-kl]acridinium salts.
    Hutchinson I; McCarroll AJ; Heald RA; Stevens MF
    Org Biomol Chem; 2004 Jan; 2(2):220-8. PubMed ID: 14737646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic strategies to a telomere-targeted pentacyclic heteroaromatic salt.
    Hutchinson I; Stevens MF
    Org Biomol Chem; 2007 Jan; 5(1):114-20. PubMed ID: 17164914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors.
    Heald RA; Stevens MF
    Org Biomol Chem; 2003 Oct; 1(19):3377-89. PubMed ID: 14584801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agents.
    Cheng MK; Modi C; Cookson JC; Hutchinson I; Heald RA; McCarroll AJ; Missailidis S; Tanious F; Wilson WD; Mergny JL; Laughton CA; Stevens MF
    J Med Chem; 2008 Feb; 51(4):963-75. PubMed ID: 18247546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
    J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino- and glycoconjugates of pyrido[4,3,2-kl]acridine. Synthesis, antitumor activity, and DNA binding.
    Bouffier L; Baldeyrou B; Hildebrand MP; Lansiaux A; David-Cordonnier MH; Carrez D; Croisy A; Renaudet O; Dumy P; Demeunynck M
    Bioorg Med Chem; 2006 Nov; 14(22):7520-30. PubMed ID: 16879973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts.
    Heald RA; Modi C; Cookson JC; Hutchinson I; Laughton CA; Gowan SM; Kelland LR; Stevens MF
    J Med Chem; 2002 Jan; 45(3):590-7. PubMed ID: 11806711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of modified acridines: the effect of N- and O- substituent in the nitrogenated ring on antitumor activity.
    Sánchez I; Reches R; Caignard DH; Renard P; Pujol MD
    Eur J Med Chem; 2006 Mar; 41(3):340-52. PubMed ID: 16413635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor polycyclic acridines. 17. Synthesis and pharmaceutical profiles of pentacyclic acridinium salts designed to destabilize telomeric integrity.
    Cookson JC; Heald RA; Stevens MF
    J Med Chem; 2005 Nov; 48(23):7198-207. PubMed ID: 16279778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of the G-quadruplex ligand RHPS4 (3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate) is associated with telomere capping alteration.
    Leonetti C; Amodei S; D'Angelo C; Rizzo A; Benassi B; Antonelli A; Elli R; Stevens MF; D'Incalci M; Zupi G; Biroccio A
    Mol Pharmacol; 2004 Nov; 66(5):1138-46. PubMed ID: 15304549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.
    Vispé S; Vandenberghe I; Robin M; Annereau JP; Créancier L; Pique V; Galy JP; Kruczynski A; Barret JM; Bailly C
    Biochem Pharmacol; 2007 Jun; 73(12):1863-72. PubMed ID: 17391647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents.
    Martins C; Gunaratnam M; Stuart J; Makwana V; Greciano O; Reszka AP; Kelland LR; Neidle S
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2293-8. PubMed ID: 17276687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel 4,5-bis(dialkylaminoalkyl)-substituted acridines as potent telomeric G-quadruplex ligands.
    Laronze-Cochard M; Kim YM; Brassart B; Riou JF; Laronze JY; Sapi J
    Eur J Med Chem; 2009 Oct; 44(10):3880-8. PubMed ID: 19467742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemiluminescent 10-methyl-acridinium-9-(N-sulphonylcarboxamide) salts. Synthesis and kinetics of light emission.
    Mattingly PG
    J Biolumin Chemilumin; 1991; 6(2):107-14. PubMed ID: 1882703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, antitumor cytotoxicity, and DNA-binding of novel N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides.
    Antonini I; Polucci P; Magnano A; Martelli S
    J Med Chem; 2001 Sep; 44(20):3329-33. PubMed ID: 11563932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents.
    Antonini I; Polucci P; Magnano A; Cacciamani D; Konieczny MT; Paradziej-Łukowicz J; Martelli S
    Bioorg Med Chem; 2003 Feb; 11(3):399-405. PubMed ID: 12517435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
    Antonini I
    Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acridine and its derivatives: a patent review (2009 - 2013).
    Zhang B; Li X; Li B; Gao C; Jiang Y
    Expert Opin Ther Pat; 2014 Jun; 24(6):647-64. PubMed ID: 24848259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High stability and high efficiency chemiluminescent acridinium compounds obtained from 9-acridine carboxylic esters of hydroxamic and sulphohydroxamic acids.
    Renotte R; Sarlet G; Thunus L; Lejeune R
    Luminescence; 2000; 15(5):311-20. PubMed ID: 11038489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.